Citigroup’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-26
| Closed | – | – | 6906 |
|
|
2022
Q1 | $0 | Buy |
+26
| New | +$395 | ﹤0.01% | 6828 |
|
|
2021
Q3 | – | Sell |
-220
| Closed | -$9K | – | 6499 |
|
|
2021
Q2 | $9K | Sell |
220
-219
| -50% | -$11.2K | ﹤0.01% | 5724 |
|
|
2021
Q1 | $29K | Sell |
439
-136
| -24% | -$9.49K | ﹤0.01% | 5042 |
|
|
2020
Q4 | $38K | Buy |
575
+481
| +512% | +$31.4K | ﹤0.01% | 6236 |
|
|
2020
Q3 | $5K | Sell |
94
-168
| -64% | -$12.9K | ﹤0.01% | 7069 |
|
|
2020
Q2 | $25K | Sell |
262
-271
| -51% | -$20.2K | ﹤0.01% | 6462 |
|
|
2020
Q1 | $27K | Buy |
533
+153
| +40% | +$16K | ﹤0.01% | 6495 |
|
|
2019
Q4 | $31K | Sell |
380
-57
| -13% | -$4K | ﹤0.01% | 6697 |
|
|
2019
Q3 | $37K | Sell |
437
-47
| -10% | -$5.02K | ﹤0.01% | 6329 |
|
|
2019
Q2 | $61K | Buy |
484
+17
| +4% | +$2.45K | ﹤0.01% | 6295 |
|
|
2019
Q1 | $85K | Sell |
467
-2
| -0.4% | -$289 | ﹤0.01% | 5908 |
|
|
2018
Q4 | $52K | Sell |
469
-72
| -13% | -$9.38K | ﹤0.01% | 6212 |
|
|
2018
Q3 | $73K | Buy |
541
+146
| +37% | +$20.1K | ﹤0.01% | 6208 |
|
|
2018
Q2 | $55K | Buy |
395
+169
| +75% | +$23.2K | ﹤0.01% | 6221 |
|
|
2018
Q1 | $31K | Sell |
226
-694
| -75% | -$94.5K | ﹤0.01% | 6493 |
|
|
2017
Q4 | $113K | Buy |
920
+914
| +15,233% | +$126K | ﹤0.01% | 5535 |
|
|
2017
Q3 | $1K | Sell |
6
-699
| -99% | -$106K | ﹤0.01% | 7184 |
|
|
2017
Q2 | $124K | Buy |
705
+681
| +2,838% | +$96.9K | ﹤0.01% | 5176 |
|
|
2017
Q1 | $3K | Sell |
24
-1,904
| -99% | -$198K | ﹤0.01% | 6962 |
|
|
2016
Q4 | $188K | Buy |
1,928
+1,753
| +1,002% | +$161K | ﹤0.01% | 5332 |
|
|
2016
Q3 | $17K | Sell |
175
-36
| -17% | -$3.61K | ﹤0.01% | 6299 |
|
|
2016
Q2 | $23K | Sell |
211
-1,386
| -87% | -$162K | ﹤0.01% | 6078 |
|
|
2016
Q1 | $192K | Buy |
1,597
+1,020
| +177% | +$107K | ﹤0.01% | 5131 |
|
|
2015
Q4 | $69K | Buy |
577
+573
| +14,325% | +$73.9K | ﹤0.01% | 5680 |
|
|
2015
Q3 | $1K | Sell |
4
-21
| -84% | -$4.03K | ﹤0.01% | 7254 |
|
|
2015
Q2 | $5K | Sell |
25
-95
| -79% | -$17.6K | ﹤0.01% | 6793 |
|
|
2015
Q1 | $18K | Sell |
120
-220
| -65% | -$33.5K | ﹤0.01% | 6154 |
|
|
2014
Q4 | $53K | Buy |
340
+243
| +251% | +$35K | ﹤0.01% | 5657 |
|
|
2014
Q3 | $14K | Buy |
97
+50
| +106% | +$7.25K | ﹤0.01% | 6108 |
|
|
2014
Q2 | $6K | Sell |
47
-271
| -85% | -$34.4K | ﹤0.01% | 6402 |
|
|
2014
Q1 | $39K | Sell |
318
-548
| -63% | -$59.4K | ﹤0.01% | 5655 |
|
|
2013
Q4 | $92K | Buy |
866
+527
| +155% | +$51.1K | ﹤0.01% | 5313 |
|
|
2013
Q3 | $38K | Sell |
339
-477
| -58% | -$54.1K | ﹤0.01% | 5497 |
|
|
2013
Q2 | $92K | Buy |
+816
| New | +$99.8K | ﹤0.01% | 4934 |
|
Other funds holding SRGA
AWS
CLG
Citigroup's SRGA Position: Q2 2022 in Review
Citigroup sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 26 shares.
Citigroup first reported a position in SRGA in Q2 2013 and held it in 34 quarters. The position peaked at $192K in Q1 2016. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.
- Citigroup reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- Citigroup sold 26 Surgalign Holdings, Inc. Common Stock shares in Q2 2022.
- Citigroup first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 34 quarters.
- Citigroup's Surgalign Holdings, Inc. Common Stock position peaked at $192K in Q1 2016.
- 40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.
Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.